A REASSESSMENT OF FASTING PLASMA-GLUCOSE CONCENTRATIONS IN POPULATION SCREENING FOR DIABETES-MELLITUS IN A COMMUNITY OF NORTHERN EUROPEAN ANCESTRY - THE WADENA CITY HEALTH STUDY

被引:8
作者
CLEMENTS, JP
FRENCH, LR
BOEN, JR
SPRAFKA, JM
HEDLUND, B
GOETZ, FC
机构
[1] UNIV MINNESOTA,MINNESOTA DEPT HLTH,CHRON DIS & ENVIRONM EPIDEMIOL SECT,MINNEAPOLIS,MN 55440
[2] UNIV MINNESOTA,DIV BIOSTAT,MINNEAPOLIS,MN 55455
[3] UNIV MINNESOTA,DIV EPIDEMIOL,MINNEAPOLIS,MN 55455
[4] UNIV MINNESOTA,BIOMED FRONTIERS INC,MINNEAPOLIS,MN 55455
[5] UNIV MINNESOTA,DEPT MED,MINNEAPOLIS,MN 55455
关键词
FASTING PLASMA GLUCOSE; DIABETES MELLITUS; EPIDEMIOLOGY;
D O I
10.1007/BF00571949
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In current clinical and research practice, the determination of diabetic status depends largely on plasma glucose levels 2 h after the ingestion of a standard 75-g glucose load, the oral glucose tolerance test (OGTT). The OGTT, however, remains inconvenient, not highly reproducible, and costly, especially for large-scale studies and population screening tests. Fasting plasma glucose (FPG) determinations are convenient, reliable, and valid measures of glucose intolerance, but the currently prescribed cut-off point of 140 mg/dl (7.8 mM) lacks sensitivity. We evaluated the reliability and validity of fasting plasma glucose (FPG) values compared with other measures of hyperglycemia for a diagnosis of diabetes in a population-based study of carbohydrate metabolism in Wadena, Minnesota, a community of predominantly northern European ancestry. As a part of this effort, a random sample of Wadena adults, stratified by age and gender, plus all known, previously diagnosed diabetics participated in 2 days of baseline testing and were followed prospectively and retested 5 years later. Cross-sectional analyses of baseline data are presented in this article. Diabetic status was ascertained by administering a standard OGTT according to National Diabetes Data Group (NDDG) specifications. Sensitivity and specificity levels obtained when using a FPG cut-off point of 6.4 mM were 95.2% and 97.4%, respectively. In study subjects with no known diagnosis of diabetes, the FPG cut-off point of 6.4 mM performed reasonably well with a sensitivity and specificity of 67.7% and 97.4%, respectively. A receiver operating characteristic (ROC) curve analysis showed that FPG consistently performed better than glycosylated hemoglobin in distinguishing diabetic from non-diabetic subjects. FPG concentrations accurately and reliably discriminate diabetic from non-diabetic individuals in a population-based study of Caucasians of northern European ancestry.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 35 条
[1]  
[Anonymous], 1990, SPSS REFERENCE GUIDE
[3]  
BENDER AP, 1983, MINN MED, V66, P251
[4]   INCIDENCE, PREVALENCE, AND MORTALITY OF DIABETES-MELLITUS IN WADENA, MARSHALL, AND GRAND-RAPIDS, MINNESOTA - THE 3-CITY STUDY [J].
BENDER, AP ;
SPRAFKA, JM ;
JAGGER, HG ;
MUCKALA, KH ;
MARTIN, CP ;
EDWARDS, TR .
DIABETES CARE, 1986, 9 (04) :343-350
[5]  
BENDER AP, 1983, MINN MED, V66, P383
[6]   DIABETES-MELLITUS IN TECUMSEH, MICHIGAN - PREVALENCE, INCIDENCE, AND ASSOCIATED CONDITIONS [J].
BUTLER, WJ ;
OSTRANDER, LD ;
CARMAN, WJ ;
LAMPHIEAR, DE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1982, 116 (06) :971-980
[7]   ASSESSMENT OF GLUCOSE-TOLERANCE TEST CRITERIA FOR DIAGNOSIS OF DIABETES IN CHINESE SUBJECTS [J].
COCKRAM, CS ;
LAU, JTF ;
CHAN, AYW ;
WOO, J ;
SWAMINATHAN, R .
DIABETES CARE, 1992, 15 (08) :988-990
[8]   DETERMINING DIABETES PREVALENCE - A RATIONAL BASIS FOR THE USE OF FASTING PLASMA-GLUCOSE CONCENTRATIONS [J].
FINCH, CF ;
ZIMMET, PZ ;
ALBERTI, KGMM .
DIABETIC MEDICINE, 1990, 7 (07) :603-610
[9]   BIMODALITY OF GLYCOSYLATED HEMOGLOBIN DISTRIBUTION IN PIMA-INDIANS - RELATIONSHIP TO FASTING HYPERGLYCEMIA [J].
FLOCK, EV ;
BENNETT, PH ;
SAVAGE, PJ ;
WEBNER, CJ ;
HOWARD, BV ;
RUSHFORTH, NB ;
MILLER, M .
DIABETES, 1979, 28 (11) :984-989
[10]   POPULATION-BASED STUDY OF IMPAIRED GLUCOSE-TOLERANCE AND TYPE-II DIABETES IN WADENA, MINNESOTA [J].
FRENCH, LR ;
BOEN, JR ;
MARTINEZ, AM ;
BUSHHOUSE, SA ;
SPRAFKA, JM ;
GOETZ, FC .
DIABETES, 1990, 39 (09) :1131-1137